ORACLE CORP SEC Filing

ORCL common stock holder filed a notice to sell 10,000 shares through Fidelity Brokerage Services LLC on or after December 19, 2025, with an aggregate market value of 1,925,152.18.

Accepted by SEC EDGAR 12/19/2025 - 12:43 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

ORCL common stock holder filed a notice to sell 10,000 shares through Fidelity Brokerage Services LLC on or after December 19, 2025, with an aggregate market value of 1,925,152.18. These shares were acquired on September 20, 2025 via restricted stock vesting from the issuer as compensation.

Over the prior three months, the same seller, Clayton Magouyrk, sold 40,000 common shares on October 21, 2025 for gross proceeds of 11,065,506.10. The issuer reported 2,873,130,000 common shares outstanding, and the securities are listed on the NYSE.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ORCL common shares are planned for sale in this Form 144?

The notice covers the planned sale of 10,000 shares of ORCL common stock, to be sold through Fidelity Brokerage Services LLC on or about December 19, 2025.

What is the aggregate market value of the ORCL shares to be sold?

The 10,000 ORCL common shares planned for sale have an aggregate market value of 1,925,152.18 according to the disclosure.

How and when were the ORCL shares in this Form 144 acquired?

The 10,000 ORCL common shares were acquired on September 20, 2025 via restricted stock vesting from the issuer, described as compensation.

What ORCL stock sales has the filer made in the last three months?

During the prior three months, Clayton Magouyrk sold 40,000 ORCL common shares on October 21, 2025, generating gross proceeds of 11,065,506.10.

How many ORCL common shares are outstanding according to this notice?

The disclosure states that the issuer has 2,873,130,000 ORCL common shares outstanding.

On which exchange are the ORCL shares in this Form 144 listed?

The common shares referenced in this notice are listed on the NYSE.

What representation does the seller make about information on the issuer?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002071873
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORACLE CORP
SEC File Number	001-35992
Address of Issuer	2300 ORACLE WAY AUSTIN TEXAS 78741
Phone	(737) 867-1000
Name of Person for Whose Account the Securities are To Be Sold	Magouyrk Clayton M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	1925152.18	2873130000	12/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/20/2025	Restricted Stock Vesting	Issuer			10000	09/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Clayton Magouyrk 2300 Oracle Way Austin TX 78741	Common	10/21/2025	40000	11065506.10

144: Remarks and Signature

Remarks
Date of Notice	12/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Clayton Magouyrk
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)